National Comprehensive Cancer Network



About NCCN

Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel - Disclosures as of 6/17/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Wallace Akerley, MD

None

Genentech, Inc.

None

None

3/5/2013

Hossein Borghaei, DO, MS

None

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.

None

None

7/2/2012

Andrew C. Chang, MD

None

None

None

None

5/15/2013

Richard T. Cheney, MD

None

None

None

None

1/17/2014

Lucian R. Chirieac, MD

None

None

None

None

9/27/2013

Thomas A. D'Amico, MD

None

Covidien AG;
Scanlan

None

None

3/26/2014

Todd L. Demmy, MD

None

None

None

None

12/20/2013

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Biodesix

None

None

10/8/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Apar Kishor P. Ganti, MD

None

None

None

None

4/22/2014

Ramaswamy Govindan, MD

None

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
GlaxoSmithKline

None

None

9/10/2013

Frederic W. Grannis, MD

None

Steven Phillips (sphillips@lpklaw.com)

None

None

9/20/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Leora Horn, MD, MSc, FRCPC

None

None

None

None

7/12/2013

Miranda Hughes, PhD

None

None

None

None

4/21/2014

Thierry M. Jahan, MD

None

Poniard Pharmaceuticals

None

None

4/16/2013

Mohammad Jahanzeb, MD, FACP

None

Genentech, Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

3/1/2012

Anne Kessinger, MD

Pharmacyclics;
sanofi-aventis U.S.

None

None

None

5/4/2011

Ritsuko Komaki, MD

None

None

None

None

7/8/2013

Feng-Ming (Spring) Kong, MD, PhD

None

None

None

None

10/9/2012

Mark G. Kris, MD

None

Boehringer Ingelheim GmbH;
Covidien AG;
National Cancer Institute;
Chugai Pharmaceuticals;
Clovis Oncology;
Pfizer Inc.

None

None

3/4/2013

Lee M. Krug, MD

Eli Lilly and Company;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
CanBas

Genentech, Inc.;
Morphotek Inc.

None

None

6/18/2012

Inga T. Lennes, MD, MPH

None

None

None

None

1/28/2014

Billy W. Loo, MD, PhD

None

General Electric;
Varian Medical Systems, Inc.

None

None

4/22/2014

Renato Martins, MD, MPH

None

Eli Lilly and Company;
Genentech, Inc.

None

None

3/28/2014

Joan S. McClure, MS

None

None

None

None

8/13/2013

Janis O'Malley, MD

None

None

None

None

4/13/2011

Raymond U. Osarogiagbon, MD, FACP

Bristol-Myers Squibb Company;
Eli Lilly and Company

Genentech, Inc.;
OSI Pharmaceuticals, Inc.

None

None

6/15/2011

Gregory A. Otterson, MD

None

Abraxis Bioscience, Inc.;
Genentech, Inc.

None

None

6/27/2013

Jyoti D. Patel, MD

None

Genentech, Inc.

None

None

9/10/2013

Mary C. Pinder-Schenck, MD

None

None

None

None

7/3/2012

Katherine M. Pisters, MD

None

None

None

None

4/10/2013

Karen Reckamp, MD, MS

None

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Response Genetics;
Tragara Pharmaceuticals

None

None

3/13/2014

Gregory J. Riely, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Chugai;
Tragara

None

None

8/16/2012

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

Scott Swanson, MD

None

Covidien AG;
Ethicon, Inc.

None

None

7/5/2012

Douglas E. Wood, MD

None

None

None

None

5/11/2013

Stephen C. Yang, MD

None

None

None

None

6/18/2012